GF Fund Management Co Ltd. - China Securities Innovative Pharma Index ETF (SHA:515120)

China flag China · Delayed Price · Currency is CNY
0.6490
+0.0020 (0.31%)
Apr 2, 2026, 4:00 PM EDT
Assetsn/a
Expense Ration/a
PE Ratio28.61
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
1-Year Return+13.66%
Volume994,202,540
Open0.6470
Previous Close0.6470
Day's Range0.6390 - 0.6560
52-Week Low0.4910
52-Week High0.7710
Beta0.41
Holdings88
Inception DateDec 3, 2020

About 515120

515120.SS was created on 2020-12-03 by GF Fund. The fund's investment portfolio concentrates primarily on health care equity. Tightly track the target index, pursue the minimization of tracking deviation and tracking error. The Fund strives to control the absolute value of the daily average tracking deviation between the net value growth rate of the investment portfolio & the performance benchmark is less than 0.2% & the annualized tracking deviation is less than 0.2%.

Asset Class Equity
Category Health Care
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 515120
Provider GF Fund
Index Tracked CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross

Performance

515120 had a total return of 13.66% in the past year, including dividends. Since the fund's inception, the average annual return has been -8.28%.

Top 10 Holdings

44.50% of assets
NameSymbolWeight
WuXi AppTec Co., Ltd.60325910.30%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd6002769.93%
Huadong Medicine Co., Ltd0009633.37%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.6001963.28%
Sichuan Kelun Pharmaceutical Co., Ltd.0024223.20%
BeOne Medicines AG6882353.00%
Changchun High-Tech Industry (Group) Co., Ltd.0006612.95%
Pharmaron Beijing Co., Ltd.3007592.87%
Hangzhou Tigermed Consulting Co., Ltd3003472.86%
Shanghai Allist Pharmaceuticals Co., Ltd.6885782.75%
View More Holdings